Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
T.ATE
Alternate Symbol(s):
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ATE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 10:48am
The one two punch📉
that has antibe on life supprt Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the
...more
(13)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 01, 2024 10:35am
Mugsy you are awfully quiet today
C cat got your tongue?
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(13)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Comment by
SimonSaysLues
on Apr 01, 2024 10:24am
RE:RE:RE:Acquisition
I believe the ate building is Dan's ....
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Apr 01, 2024 10:13am
RE:RE:RE:Acquisition
Depends on the rationale for the pause. I was expecting litigation but the pause speaks to the science. IDK...
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Comment by
mstrmnds
on Apr 01, 2024 10:11am
RE:RE:Acquisition
The assets are worth exponentially more than the current market cap It's going to be acquired
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 10:05am
RE:Acquisition
are you that foolish, have you not lost enough yet, my guess is dan did not tell you about this in your conversation. or was there a conversation at all i still call B.S.
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 01, 2024 9:57am
It is over
the dead carcass of what was antibe is now being picked away at by day traders and the vultures, nuance wants there money and will be forced to go through the process, while antibe slowly burns the
...more
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 01, 2024 9:53am
Acquisition
Added another 100K This company will likely be acquired
(13)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 01, 2024 9:53am
Clown car with Dan/Mugs at the helm!
Mugs still full of optimism. !! Time to buy lol.
(3)
•••
CalmBeforeStorm
X
View Profile
View Bullboard History
Comment by
CalmBeforeStorm
on Apr 01, 2024 9:52am
RE:Painful lesson
I'm going to be on the French Riviera in a few days. Perhaps I should make a point a making a few minutes detour to the sailing community of Antibes to see if there are any boats flying Canadian
...more
(379)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Apr 01, 2024 9:43am
RE:Painful lesson
Yep. CalmBeforeStorm...A lot of us got burnt when this was trading at 4.50 and liver problems were "surprisingly announced.". Anyone investing in this after reviewing what lead up to that
...more
(805)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Apr 01, 2024 9:15am
RE:RE:Was that pez
sorry for your loss mugs, in my opinion i would get out as fast as humanly possible at the open this morning.
(3)
•••
CalmBeforeStorm
X
View Profile
View Bullboard History
Post by
CalmBeforeStorm
on Apr 01, 2024 9:03am
Painful lesson
Painful lesson for, admittedly, having "played" in an arena I didn't belong in as an investor... Have been holding on for a long time. I feel like I lined the pockets of
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 01, 2024 7:08am
New Press Release - Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical hold, postponing the initiation of the...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results